Related Experiment Video
Updated: Jul 19, 2026

Quantification of Intracellular Growth Inside Macrophages is a Fast and Reliable Method for Assessing the Virulence of Leishmania Parasites
Published on: March 16, 2018
Leishmania (L.) amazonensis LaLRR17 increases parasite entry in macrophage by a mechanism dependent on GRP78
Mauricio S Peña1, Fenny Hui Fen Tang2, Fernando Alves de Lima Franco1
1Department of Parasitology, Institute of Biomedical Sciences, University of São Paulo, São Paulo, Brazil.
Abstract:
Leishmaniases affect 12 million people worldwide. They are caused by Leishmania spp., protozoan parasites transmitted to mammals by female phlebotomine flies. During the life cycle, promastigote forms of the parasite live in the gut of infected sandflies and convert into amastigotes inside the vertebrate macrophages. The parasite evades macrophage's microbicidal responses due to virulence factors that affect parasite phagocytosis, survival and/or proliferation. The interaction between Leishmania and macrophage molecules is essential to phagocytosis and parasite survival. Proteins containing leucine-rich repeats (LRRs) are common in several organisms, and these motifs are usually involved in protein–protein interactions. We have identified the LRR17 gene, which encodes a protein with 6 LRR domains, in the genomes of several Leishmania species. We show here that promastigotes of Leishmania (L.) amazonensis overexpressing LaLRR17 are more infective in vitro. We produced recombinant LaLRR17 protein and identified macrophage 78 kDa glucose-regulated protein (GRP78) as a ligand for LaLRR17 employing affinity chromatography followed by mass spectrometry. We showed that GRP78 binds to LaLRR17 and that its blocking precludes the increase of infection conferred by LaLRR17. Our results are the first to report LRR17 gene and protein, and we hope they stimulate further studies on how this protein increases phagocytosis of Leishmania.
Insights
Leishmania parasites use a leucine-rich repeat protein (LaLRR17) to enhance macrophage infection. Blocking this protein interaction with macrophage GRP78 reduces parasite infectivity, offering a potential therapeutic target.
Area of Science:
- Parasitology
- Molecular Biology
- Immunology
Background:
- Leishmaniases are widespread protozoan parasitic diseases.
- Leishmania parasites evade host macrophage defenses.
- Leucine-rich repeat (LRR) proteins mediate protein-protein interactions.
Purpose of the Study:
- To identify and characterize novel Leishmania virulence factors.
- To investigate the role of LRR17 in Leishmania pathogenesis.
- To explore the interaction between Leishmania and host macrophage molecules.
Main Methods:
- Gene identification and overexpression in Leishmania (L.) amazonensis.
- Recombinant protein production and purification.
- Affinity chromatography and mass spectrometry for ligand identification.
- In vitro infection assays to assess parasite infectivity.
Main Results:
- The LRR17 gene was identified in Leishmania species.
- Overexpression of LaLRR17 increased Leishmania promastigote infectivity in vitro.
- Macrophage GRP78 was identified as a ligand for LaLRR17.
- Blocking the LaLRR17-GRP78 interaction reduced parasite infectivity.
Conclusions:
- Leishmania LRR17 is a novel virulence factor.
- LaLRR17 facilitates Leishmania entry into macrophages by interacting with GRP78.
- Targeting the LaLRR17-GRP78 interaction may offer a strategy for leishmaniasis treatment.
Related Concept Videos
Leishmaniasis
American Trypanosomiasis
Amebiasis
Antiprotozoal Agents

